Morphological alterations induced by cytochalasin D on serous cells of human submandibular gland in basal and stimulated conditions.
Cytochalasin D (CD) is a fungal toxin which binds to the faster growing end of actin microfilament and inhibits actin polymerization. By an in vitro incubation system of slices of human submandibular glands obtained at surgery, we investigated by light microscope (LM), transmission electron microscope (TEM), and high resolution scanning electron microscope (HRSEM) the morphological changes caused by CD on serous cells. We studied the effects of the drug on secretory events induced by isoproterenol (I) and carbachol (C). With LM, following CD incubation, canaliculi were enlarged and prominent vacuoles were seen throughout the cytoplasm. By TEM, the vacuoles, which in many cases were in continuity with the lumen, represented the distinctive feature of secretory cells. With HRSEM, intercellular canaliculi, seen from their cytoplasmic side, exhibited many small spherical bulges, corresponding to the coated pits seen with TEM and indicating that the retrieval of plasma membrane was arrested at an early phase by the disruption of the actin cytoskeleton. In specimens treated with secretagogues and CD, a consequence reported here for the first time was the presence of dense granules within the vacuoles. The protrusions seen by HRSEM on the cytoplasmic side of intercellular canaliculi, following secretagogues stimulations, appeared peculiar to each stimulants, even if combined with CD, suggesting that besides actin filaments, other components, unaffected by CD, also are involved in the process of exocytosis and related phenomena.
Loy
F
F
Department of Cytomorphology, University of Cagliari, Cagliari, Italy.
Puxeddu
R
R
Isola
M
M
Loffredo
F
F
Riva
A
A
Testa Riva
F
F
D008841:Actin Cytoskeleton / Q000378:metabolism / Q000648:ultrastructure; D000328:Adult; D000368:Aged; D002217:Carbachol / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism / Q000648:ultrastructure; D018679:Cholinergic Agonists / Q000494:pharmacology; D015638:Cytochalasin D / Q000494:pharmacology*; D022162:Cytoplasmic Vesicles / Q000378:metabolism / Q000648:ultrastructure; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D005089:Exocytosis / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D012463:Saliva / Q000737:chemistry / Q000378:metabolism*; D013363:Submandibular Gland / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D013566:Sympathomimetics / Q000494:pharmacology; D014617:Vacuoles / Q000378:metabolism / Q000648:ultrastructure
D018679:Cholinergic Agonists; D019384:Nucleic Acid Synthesis Inhibitors; D013566:Sympathomimetics; D015638:Cytochalasin D; D002217:Carbachol; D007545:Isoproterenol